Hb Bart单克隆和多克隆抗体在α地中海贫血检测中的应用

L. Makonkawkeyoon, Somphon Pharephan, W. Tuntiwechapikul, S. Makonkawkeyoon
{"title":"Hb Bart单克隆和多克隆抗体在α地中海贫血检测中的应用","authors":"L. Makonkawkeyoon, Somphon Pharephan, W. Tuntiwechapikul, S. Makonkawkeyoon","doi":"10.2174/1874276900903010011","DOIUrl":null,"url":null,"abstract":"Using a mouse monoclonal antibody (mAb) (“2D4”) with high specific reactivity to Hb Bart’s and a rabbit polyclonal antibody (“RPB”) with high reactivity to Hb Bart’s but low reactivity to HbF, an ELISA assay was developed for the quantification of Hb Bart’s in hemolysates of peripheral blood. In the preliminary study, hemoglobin solutions containing 4,000 μg/mL of hemoglobin were analyzed for the concentration of Hb Bart’s in samples collected from the following children and adult subjects of HbH families: 12 children with deletional HbH disease (--/3.7 ) or nondeletional HbH disease (HbH disease with HbCS) (--/ cs ), 12 adults with 0 thalassemia (--/ ), 12 adults with deletional or nondeletional + thalassemia (3.7 / or / cs ) and 12 normal adult subjects ( / ). The mean ± S.D. of Hb Bart’s concentration in those with deletional HbH disease or HbH disease with HbCS, 0 thalassemia, deletional or nondeletional + thalassemia, and normal subjects were 1,374±210 (range 1,164-1,584), 1,118±357 (range 761-1,475), 451 ± 230 (range 221-681), and 0 ng/mL, respectively. When the developed ELISA was further evaluated with additional samples of various types of thalassemia, including: 18 with deletional HbH disease (--/3.7 ); 21 of nondeletional HbH disease (HbH disease with HbCS) (--/ cs ); 33 with 0 thalassemia (--/ ); 19 with nondeletional + thalassemia ( / cs ); 11 with deletional + thalassemia (3.7 / ) and 58 normal subjects ( / ). It was found that the levels of Hb Bart’s in deletional + thalassemia was significantly lower than in 0 thalassemia (p<0.001). The levels of Hb Bart’s in 0 thalassemia was also significantly lower than in nondeletional and deletional HbH diseases (p=0.023 and p<0.001, respectively). When all types of thalassemia were compared with normal subjects, the Hb Bart’s levels in all types of thalassemia were significantly higher (p<0.0001). All of our results indicated that the developed ELISA was highly sensitive and specific for quantitative determination of Hb Bart’s in hemolysates. The ELISA assay might be used as a rapid screening test for the detection of thalassemias in general population.","PeriodicalId":89702,"journal":{"name":"Open journal of hematology","volume":"51 1","pages":"11-17"},"PeriodicalIF":0.0000,"publicationDate":"2009-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Application of Monoclonal and Polyclonal Antibodies to Hb Bart’s for the Detection of α Thalassemias\",\"authors\":\"L. Makonkawkeyoon, Somphon Pharephan, W. Tuntiwechapikul, S. Makonkawkeyoon\",\"doi\":\"10.2174/1874276900903010011\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Using a mouse monoclonal antibody (mAb) (“2D4”) with high specific reactivity to Hb Bart’s and a rabbit polyclonal antibody (“RPB”) with high reactivity to Hb Bart’s but low reactivity to HbF, an ELISA assay was developed for the quantification of Hb Bart’s in hemolysates of peripheral blood. In the preliminary study, hemoglobin solutions containing 4,000 μg/mL of hemoglobin were analyzed for the concentration of Hb Bart’s in samples collected from the following children and adult subjects of HbH families: 12 children with deletional HbH disease (--/3.7 ) or nondeletional HbH disease (HbH disease with HbCS) (--/ cs ), 12 adults with 0 thalassemia (--/ ), 12 adults with deletional or nondeletional + thalassemia (3.7 / or / cs ) and 12 normal adult subjects ( / ). The mean ± S.D. of Hb Bart’s concentration in those with deletional HbH disease or HbH disease with HbCS, 0 thalassemia, deletional or nondeletional + thalassemia, and normal subjects were 1,374±210 (range 1,164-1,584), 1,118±357 (range 761-1,475), 451 ± 230 (range 221-681), and 0 ng/mL, respectively. When the developed ELISA was further evaluated with additional samples of various types of thalassemia, including: 18 with deletional HbH disease (--/3.7 ); 21 of nondeletional HbH disease (HbH disease with HbCS) (--/ cs ); 33 with 0 thalassemia (--/ ); 19 with nondeletional + thalassemia ( / cs ); 11 with deletional + thalassemia (3.7 / ) and 58 normal subjects ( / ). It was found that the levels of Hb Bart’s in deletional + thalassemia was significantly lower than in 0 thalassemia (p<0.001). The levels of Hb Bart’s in 0 thalassemia was also significantly lower than in nondeletional and deletional HbH diseases (p=0.023 and p<0.001, respectively). When all types of thalassemia were compared with normal subjects, the Hb Bart’s levels in all types of thalassemia were significantly higher (p<0.0001). All of our results indicated that the developed ELISA was highly sensitive and specific for quantitative determination of Hb Bart’s in hemolysates. The ELISA assay might be used as a rapid screening test for the detection of thalassemias in general population.\",\"PeriodicalId\":89702,\"journal\":{\"name\":\"Open journal of hematology\",\"volume\":\"51 1\",\"pages\":\"11-17\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2009-05-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Open journal of hematology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1874276900903010011\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open journal of hematology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874276900903010011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

摘要

使用对Hb Bart具有高特异性反应性的小鼠单克隆抗体(mAb)(“2D4”)和对Hb Bart具有高反应性但对HbF反应性低的兔多克隆抗体(“RPB”),开发了一种用于外周血溶血物中Hb Bart定量的ELISA检测方法。在初步研究中,从以下HbH家族的儿童和成人受试者中采集样本,分析含有4000 μg/mL血红蛋白的血红蛋白溶液中Hb Bart 's的浓度:12名患有缺失型HbH病(- /3.7)或非缺失型HbH病(HbH病伴HbCS) (- / cs)的儿童,12名患有0型地中海贫血(- /)的成人,12名患有缺失型或非缺失型+地中海贫血(3.7 /或/ cs)的成人和12名正常成人(/)。在HbH疾病缺失或HbH疾病合并HbCS、0地中海贫血、缺失或非缺失+地中海贫血和正常受试者中,Hb Bart浓度的平均±sd分别为1374±210(范围1164 - 1584)、1118±357(范围761- 1475)、451±230(范围221-681)和0 ng/mL。当用不同类型的地中海贫血的额外样本进一步评估开发的ELISA时,包括:18例HbH缺失疾病(- /3.7);21例非缺失性HbH病(HbH病伴HbCS)(—/ cs);33例地中海贫血(- /);19例非缺失+地中海贫血(/ cs);缺失+地中海贫血11例(3.7 /),正常人58例(/)。结果发现,缺失+型地中海贫血的Hb Bart 's水平显著低于0型地中海贫血(p<0.001)。0地中海贫血的Hb Bart水平也显著低于非缺失性和缺失性HbH疾病(p=0.023和p<0.001)。当所有类型的地中海贫血与正常受试者比较时,所有类型地中海贫血的Hb Bart水平均显著升高(p<0.0001)。所有结果表明,所开发的ELISA对溶血物中Hb Bart的定量测定具有高度的敏感性和特异性。该方法可作为一种快速筛选地中海贫血的检测方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Application of Monoclonal and Polyclonal Antibodies to Hb Bart’s for the Detection of α Thalassemias
Using a mouse monoclonal antibody (mAb) (“2D4”) with high specific reactivity to Hb Bart’s and a rabbit polyclonal antibody (“RPB”) with high reactivity to Hb Bart’s but low reactivity to HbF, an ELISA assay was developed for the quantification of Hb Bart’s in hemolysates of peripheral blood. In the preliminary study, hemoglobin solutions containing 4,000 μg/mL of hemoglobin were analyzed for the concentration of Hb Bart’s in samples collected from the following children and adult subjects of HbH families: 12 children with deletional HbH disease (--/3.7 ) or nondeletional HbH disease (HbH disease with HbCS) (--/ cs ), 12 adults with 0 thalassemia (--/ ), 12 adults with deletional or nondeletional + thalassemia (3.7 / or / cs ) and 12 normal adult subjects ( / ). The mean ± S.D. of Hb Bart’s concentration in those with deletional HbH disease or HbH disease with HbCS, 0 thalassemia, deletional or nondeletional + thalassemia, and normal subjects were 1,374±210 (range 1,164-1,584), 1,118±357 (range 761-1,475), 451 ± 230 (range 221-681), and 0 ng/mL, respectively. When the developed ELISA was further evaluated with additional samples of various types of thalassemia, including: 18 with deletional HbH disease (--/3.7 ); 21 of nondeletional HbH disease (HbH disease with HbCS) (--/ cs ); 33 with 0 thalassemia (--/ ); 19 with nondeletional + thalassemia ( / cs ); 11 with deletional + thalassemia (3.7 / ) and 58 normal subjects ( / ). It was found that the levels of Hb Bart’s in deletional + thalassemia was significantly lower than in 0 thalassemia (p<0.001). The levels of Hb Bart’s in 0 thalassemia was also significantly lower than in nondeletional and deletional HbH diseases (p=0.023 and p<0.001, respectively). When all types of thalassemia were compared with normal subjects, the Hb Bart’s levels in all types of thalassemia were significantly higher (p<0.0001). All of our results indicated that the developed ELISA was highly sensitive and specific for quantitative determination of Hb Bart’s in hemolysates. The ELISA assay might be used as a rapid screening test for the detection of thalassemias in general population.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信